Raiso doubles Q3 profits

By staff reporter

- Last updated on GMT

Related tags: Profit

Raisio, the Finnish plant stanol supplier and maker of the Benecol cholesterol-lowering consumer brand, reports third quarter profits of €7.6m, a 100 per cent increase on Q3 in 2007.

In the same period, sales increased by 22.5 per cent to €134.5m compared with €109.8m in 2007.

All divisions improved their operating results and Raisio’s forecast was unchanged but Raisio noted challenges that included, “general economic uncertainty, changes in the food industry, as well as the increasing cost pressure affecting trade, industry and producers.”

Looking forward,​Raisio said all divisions are expected to remain profitable “although the pressure on profitability will continue in feed”.

The company said: “The overall operating result in the Food Division is expected to be profitable, although the target operating result rate of five per cent will probably not be achieved due to increased marketing inputs, new product launches and preparations for entry into new markets. The Ingredients Division is expected to increase its net sales and improve profitability from the previous year.”

Raisio also received a non-operating boost when a court decided it did not have to pay tax on a 2004 divestment of its chemicals division that turned a profit of €220m.

Raisio produces the Benecol plant stanol, cholesterol-lowering​ ingredient as well as Benecol cholesterol-lowering food range it sells in more than 30 countries. The range includes margarines, spreads, cream cheese-style spreads, yoghurts, yoghurt drinks, cereals, milk and soy drinks, pasta and olive oil.

Raisio had sales of €422m in 2007. The Finnish-based firm employs 1100 people in nine countries. It specialises in functional foods ingredients, feeds and malts.

Related news

Show more

Related products

show more

Skin-Gut Axis: The Potential of Pomella®

Skin-Gut Axis: The Potential of Pomella®

Gee Lawson Nutritional - LEHVOSS Group | 02-Nov-2018 | Technical / White Paper

When skin is exposed to oxidative stress, the effectiveness of the endogenic antioxidant system can be significantly compromised. Pomegranate, a natural...

K2 for Heart Health? MenaQ7 Only Proven, Patented

K2 for Heart Health? MenaQ7 Only Proven, Patented

NattoPharma USA, Inc. | 22-Oct-2018 | Research Study

Vitamin K2 has earned media and the medical community’s attention due to a strong body of evidence showing it simultaneously supports bone and cardiovascular...

 Cannabidiol: Should you invest in it?

Cannabidiol: Should you invest in it?

The Whitehouse Consultancy | 17-Oct-2018 | Technical / White Paper

An increasing number of CBD containing products are appearing on the market and consumer interest in this substance is rising.

Decoding the Six Pathways of Ageing

Decoding the Six Pathways of Ageing

Gencor | 04-Oct-2018 | Technical / White Paper

The desire to extend lifespan has been around since the beginning of time and with the growing ageing population, more and more research is being conducted...

Related suppliers

Follow us

Featured Events

View more

Products

View more

Webinars